CM
SRNE

Caption Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Caption Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,892
Closed -$32.7K – 1716
2022
Q4 		$32.7K Hold
36,892
– – ﹤0.01% 1190
2022
Q3 		$57K Buy
+36,892
New +$83.7K ﹤0.01% 1379
2020
Q2 		– Sell
-81,800
Closed -$313K – 1244
2020
Q1 		$150K Buy
+81,800
New +$236K 0.01% 731

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Caption Management's SRNE Position: Q1 2023 in Review

Caption Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 36,892 shares — an estimated $32.7K sold.

Caption Management first reported a position in SRNE in Q1 2020 and held it in 3 quarters. The position peaked at $150K in Q1 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Caption Management reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Caption Management sold 36,892 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $32.7K.
  • Caption Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2020 and held it in 3 quarters.
  • Caption Management's Sorrento Therapeutics, Inc. position peaked at $150K in Q1 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Caption Management's 13F filing for Q1 2023, filed 15 May 2023.